Arbutus Biopharma Corporation Made Big Gain

Arbutus Biopharma Corporation (ABUS:NASDAQ) soared at $6.2, a gain of 119.9%. On Wed 22 Jul 20, ABUS:NASDAQ touched a New 2-Week Intraday High of $3.06. The stock appeared on our News Catalysts scanner on Thu 23 Jul 20 at 04:43 PM in the 'BIOTECH' category. From Wed 08 Jul 20, the stock recorded 50.00% Up Days and 54.55% Green Days

The stock spiked on Thu 20 Feb 20 at $3.56 with a volume of 1M+.

About Arbutus Biopharma Corporation (ABUS:NASDAQ)

Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.